Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom.
Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium.
Vaccine. 2024 Jul 11;42 Suppl 2:S9-S15. doi: 10.1016/j.vaccine.2023.10.063. Epub 2024 Nov 7.
This article presents an overview of the main challenges and lessons learned that were presented during the symposia organized by the Coalition to Strengthen the HPV Immunization Community (CHIC) in Africa and South Asia in 2022. Discussions at these meetings revolved around introduction, planning, implementation, and sustainability of HPV prevention and control programmes, with a particular focus in HPV immunisation, as well as cervical cancer screening in South Asian countries. This article also discusses the recently endorsed off-label single-dose HPV vaccination schedule and its potential impact on programme delivery and access. Furthermore, it highlights the importance of intersectional collaboration, effective communication and advocacy strategies, and the need for robust health information systems. Some of the critical factors identified for reducing the burden of cervical cancer in low- and middle-income countries (LMICs) included strategies for increasing access and coverage, addressing vaccine hesitancy, and building capacity among health care providers. The symposia emphasized the importance of face-to-face interactions for collaboration and decision making, with live translation services enabling full participation by stakeholders from diverse backgrounds. The paper concludes with a call for continued collaboration to make progress in reducing the burden of cervical cancer in LMICs.
本文概述了 2022 年加强 HPV 免疫社区联盟(CHIC)在非洲和南亚组织的专题讨论会提出的主要挑战和经验教训。这些会议的讨论围绕 HPV 预防和控制规划的引入、规划、实施和可持续性展开,特别关注 HPV 免疫接种以及南亚国家的宫颈癌筛查。本文还讨论了最近批准的 HPV 疫苗单剂标签外使用方案及其对方案实施和可及性的潜在影响。此外,本文强调了交叉合作、有效沟通和宣传策略以及健全的卫生信息系统的重要性。为了降低中低收入国家(LMICs)的宫颈癌负担,确定了一些关键因素,包括增加获取和覆盖范围的策略、解决疫苗犹豫问题以及增强卫生保健提供者的能力。专题讨论会强调了面对面互动对于协作和决策的重要性,现场翻译服务使来自不同背景的利益攸关方能够充分参与。本文最后呼吁继续合作,在降低 LMICs 的宫颈癌负担方面取得进展。